AMORPHOUS COMPOUND

The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascula...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BROWN, JOHN, ROBERTS, RONALD, JOHN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril. La présente invention concerne une nouvelle forme de (S)-1-[N -(1-carboxy-3-phénylpropyle)-L-lysyle]-L-proline connue sous le nom générique de lisinopril. De plus, la présente invention concerne également l'utilisation de la nouvelle forme amorphe de lisinopril pour le traitement de l'hypertension et d'autres maladies cardiovasculaires, des compositions pharmaceutiques la contenant ainsi que des procédés de préparation de la nouvelle forme amorphe de lisinopril.